Mevius Pharmaceutical Co., Ltd. A new community site “MORE! SIMIUS” is born, aiming for “beauty” together by eliminating the barriers between manufacturers and users.

Mebius Pharmaceutical Co., Ltd.
A new community site “MORE! SIMIUS” is born, aiming for “beautiful” together by eliminating the barriers between manufacturers and users. A registration campaign is underway to win popular Simius (R) products!
Mobius Pharmaceutical Co., Ltd. (Headquarters: Minato-ku, Tokyo; Representative Director: Kiichi Hasegawa), which sells the all-in-one gel “SIMIUS”, which has sold more than 19 million units in the series, will be released on November 14, 2022 (Monday). We have opened a community site “MORE! SIMIUS”.
[Image

https://www.mebiusseiyaku.co.jp/camp/community/
Registration campaign in progress!
To commemorate the renewal, we are holding a registration campaign. During the campaign period, Simius (R) popular products will be presented to 30 people by lottery from those who applied.
Application period: Until Wednesday, November 30, 2022
Application method: You can apply from the “Registration campaign” page on the community site.
▼ Click here to register
https://community.mebiusseiyaku.co.jp/view/signup/email/Tuy09CBWpX?groupIds=9520 Mebius Pharmaceutical Co., Ltd.
Headquarters: 2-5-1 Akasaka, Minato-ku, Tokyo S-GATE Akasaka Sanno 6F Representative Director: Kiichi Hasegawa
Established: July 31, 2006
Business description: Manufacturing and wholesale/retail of
pharmaceuticals, cosmetics and health foods
HP: https://company.mebiusseiyaku.co.jp/

Details about this release:
https://prtimes.jp/main/html/rd/p/000000053.000023770.html


rehow

Leave a Reply

Your email address will not be published.

%d bloggers like this: